315 related articles for article (PubMed ID: 29358778)
1. Exogenous reproductive hormone use in breast cancer survivors and previvors.
Vaz-Luis I; Partridge AH
Nat Rev Clin Oncol; 2018 Apr; 15(4):249-261. PubMed ID: 29358778
[TBL] [Abstract][Full Text] [Related]
2. Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
Dean M; Davidson LG
Health Commun; 2018 Feb; 33(2):122-130. PubMed ID: 27976925
[TBL] [Abstract][Full Text] [Related]
3. "When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk.
Dean M; Scherr CL; Clements M; Koruo R; Martinez J; Ross A
Patient Educ Couns; 2017 Sep; 100(9):1738-1743. PubMed ID: 28385363
[TBL] [Abstract][Full Text] [Related]
4. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
[TBL] [Abstract][Full Text] [Related]
5. Exogenous and endogenous hormones and breast cancer.
Chen WY
Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):573-85. PubMed ID: 18971119
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
7. How reliable are the available safety data on hormonal stimulation for fertility preservation in young women with newly diagnosed early breast cancer?
Lambertini M; Fontanella C
Breast Cancer Res Treat; 2018 Apr; 168(3):773-774. PubMed ID: 29335923
[No Abstract] [Full Text] [Related]
8. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy in cancer survivors.
Biglia N; Gadducci A; Ponzone R; Roagna R; Sismondi P
Maturitas; 2004 Aug; 48(4):333-46. PubMed ID: 15283925
[TBL] [Abstract][Full Text] [Related]
10. The management of sexuality, intimacy, and menopause symptoms (SIMS) after prophylactic bilateral salpingo-oophorectomy: How to maintain sexual health in "previvors".
Alexandre M; Black J; Whicker M; Minkin MJ; Ratner E
Maturitas; 2017 Nov; 105():46-51. PubMed ID: 28602465
[TBL] [Abstract][Full Text] [Related]
11. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
12. Current evidence supporting fertility and pregnancy among young survivors of breast cancer.
Meneses K; Holland AC
J Obstet Gynecol Neonatal Nurs; 2014; 43(3):374-81. PubMed ID: 24689363
[TBL] [Abstract][Full Text] [Related]
13. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2004 Oct; 143(10):753-6, 764. PubMed ID: 15521355
[TBL] [Abstract][Full Text] [Related]
14. Hormonal factors and breast tumor proliferation: do factors that affect cancer risk also affect tumor growth?
Oestreicher N; White E; Malone KE; Porter PL
Breast Cancer Res Treat; 2004 May; 85(2):133-42. PubMed ID: 15111771
[TBL] [Abstract][Full Text] [Related]
15. [Breast Cancer - Specifics of Gynecological Care and Counseling].
Weinberger V; Zikán M
Klin Onkol; 2016; 29 Suppl 3():S7-15. PubMed ID: 28118719
[TBL] [Abstract][Full Text] [Related]
16. Fertility preservation in breast cancer patients.
El Hachem H; Atallah D; Grynberg M
Future Oncol; 2014 Aug; 10(10):1767-77. PubMed ID: 25303056
[TBL] [Abstract][Full Text] [Related]
17. "Take your time, then follow your heart:" Previvors' advice for communicating about family planning after testing positive for a BRCA genetic variant.
Rauscher EA; Dean M
Fam Syst Health; 2017 Dec; 35(4):486-497. PubMed ID: 29283615
[TBL] [Abstract][Full Text] [Related]
18. The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.
Justenhoven C; Obazee O; Brauch H
Pharmacogenomics; 2012 Apr; 13(6):659-75. PubMed ID: 22515609
[TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter].
Siegelmann-Danieli N; Ron I; Kaufman B; Uzieli B; Karminsky N; Inbar M;
Harefuah; 2002 Nov; 141(11):994-6, 1008. PubMed ID: 12476637
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy in breast cancer patients and survivors.
Del Priore G; Hatami M
Curr Womens Health Rep; 2003 Apr; 3(2):165-9. PubMed ID: 12628087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
